Float Image
Float Image
Endotech AI vs 3Commas 2026: Full Independent Comparison
Head-to-Head Comparison

Endotech vs 3Commas

Are you looking for a dashboard to manage manual bots, or a machine that manages your capital for you? Here is the full institutional breakdown.

By Limitless IB Updated March 2026 ~9 min read
3Commas
3.1/5
Rule-based bots · Monthly fee
User-configured · Varies by skill
Endotech AI (Bit1)
4.9/5
Autonomous neural AI · No monthly fee
8-yr verified record · 163% avg annual
Factor 3Commas Endotech AI (Bit1)
Automation Type Semi-Manual
Rule-based DCA/grid bots you configure
Fully Autonomous
Neural network makes all decisions
Intelligence Model Fixed Rules
RSI, MACD, Bollinger Bands — expires as markets adapt
Machine Learning
100+ AI modules · self-improves every 2-3 months
Monthly Cost $49–$200+/mo
Charged regardless of profit or loss
$0 Upfront
Performance fee only — 15% of profits when profitable
Performance History User Dependent
No platform-level track record — varies by config
8-Year Verified
163% avg annual · 83% win rate · 0 losing years
Bear Market Behaviour Vulnerable
DCA/grid bots break when price falls outside range
Resilient
Trades futures both directions · max 14% drawdown (BTC)
Setup Complexity Moderate
Requires trading knowledge to configure effectively
Under 10 mins
Register → deposit → copy trade. AI handles the rest
Custody Model API-Based
Connects to your exchange via API
Full API Custody
Funds stay in your Bit1 wallet — AI cannot withdraw
Minimum Investment Low
No capital minimum (subscription required)
None
Any amount of USDT · no minimum · free to join
Exchange Support Wide
Binance, Coinbase, Bybit, KuCoin and others
Exclusive
Bit1 Exchange only (invitation-only platform)
Founder / Team Standard SaaS
Tech product team · no trading pedigree
Dr. Anna Becker
Technion PhD · 30yr quant finance · $40M AI build

The Fundamental Difference: Tool vs System

The most important thing to understand when comparing 3Commas to Endotech is that they are not really competing in the same category. 3Commas is a tool — it gives you a dashboard to build, monitor, and manage trading bots. You decide the strategy. You configure the parameters. You absorb the consequences of those decisions. The quality of your results on 3Commas depends almost entirely on your own trading knowledge and the time you invest in configuration and monitoring.

Endotech AI is a system — a fully autonomous institutional neural network that makes its own trading decisions based on 8 years of continuous machine learning. There is no configuration. There are no indicators to set. You connect your capital via copy trading and the AI handles everything else. The only decision you make is how much USDT to put in the Futures wallet.

This distinction matters enormously for most investors. Using 3Commas effectively requires meaningful trading knowledge. You need to understand how DCA bots work, what safety orders are, how to set take-profit levels, and how to recognize market conditions where your bot configuration will fail. Most retail users on 3Commas are not profitable — not because the platform is bad, but because they are using a sophisticated tool without the expertise to configure it well.

The 3Commas Bear Market Problem

Most 3Commas DCA and grid bots are configured for sideways or upward markets. When price falls sharply and continuously — as it did in 2018, 2020, and 2022 — bots run out of safety orders, open positions accumulate at loss, and accounts can be severely damaged with no mechanism to recover. Endotech trades futures in both directions. Its maximum drawdown during Bitcoin's -94% crash in 2018 was 14%.

The Cost Structure: Monthly Fee vs Performance Model

3Commas charges $49 to $200+ per month depending on your subscription tier. This fee is charged regardless of whether your bots are profitable. If you have a losing month — which is entirely possible with user-configured bots in adverse market conditions — you are paying the subscription fee on top of your trading losses. Over 12 months, a basic 3Commas subscription costs $588 to $2,400 before you have generated a single dollar of return.

Endotech AI on Bit1 operates on a performance fee model. There is no monthly subscription. No upfront cost. No fee when the AI has a losing month. The cost structure is: 70% of trading profits go to you, 15% go to Endotech as their performance fee, and 15% go into the partner reward pool. You only pay when the system makes you money. This is how professional hedge funds charge — it aligns incentives in a way that monthly SaaS subscriptions fundamentally cannot.

Deeper Analysis

Why Serious Investors Are Moving From Bots to Institutional AI

The core limitation of rule-based trading bots — including the most sophisticated 3Commas configurations — is that they are built on fixed logical rules. When markets behave in ways the rules don't anticipate, the bots fail. The 2022 Terra/LUNA collapse, the FTX implosion, and flash crashes driven by large institutional liquidations are all examples of events where rule-based systems suffered significant losses because the rules were configured for "normal" market behavior.

Endotech's machine learning architecture is designed specifically to handle regime changes — periods when market behavior shifts in ways that invalidate prior pattern assumptions. The system's 100+ specialized AI modules continuously reassess market state classification, and the model updates every 2-3 months as new data is ingested. This is why the system's performance has improved over its 8-year life rather than degraded.

The Dr. Anna Becker factor is also relevant here. 3Commas was built by a SaaS team. Endotech was built by a Technion-credentialed PhD in AI with 30 years of quantitative finance experience, co-authorship of academic work on Bayesian networks, and a previous fintech exit. The intellectual capital behind the system is institutional-grade in a way that consumer bot platforms are not.

The exchange exclusivity of Bit1 deserves mention in the comparison. 3Commas connects to many exchanges — Binance, Coinbase, Bybit, KuCoin and others — which is a genuine advantage for users who are already established on those platforms. Bit1 is invitation-only, which requires moving capital to a new platform. This is the most legitimate friction point in the comparison.

However, the invitation-only model has structural advantages for the IB community. Every user on Bit1 must come through a referral — meaning the platform's entire user base is network-generated, and the 60% fee diversion back to the partner community reflects that. For investors who are also interested in the affiliate income dimension, Bit1's coding plan is structurally superior to anything 3Commas offers its referral partners.

For investors who simply want the best-performing system for their capital — without the SaaS monthly fee, without the configuration burden, and with the deepest track record available — the comparison is straightforward. See the full Endotech review or the Neural AI deep dive for further data.

Stop Configuring. Start Compounding.

3Commas is a tool for hobbyists. Endotech is an engine for serious investors. Bypass the monthly fees, the configuration complexity, and the bot failures — connect to institutional AI today.

Free to join · No monthly fees · Full API custody · Withdraw anytime

Common Questions

Frequently Asked Questions

3Commas is a dashboard for managing rule-based trading bots. You configure the bot settings manually — indicators, entry conditions, take-profit levels, stop-losses. Results depend entirely on your trading knowledge. Endotech AI is a fully autonomous institutional neural network that makes all trading decisions independently based on machine learning analysis of global market data. No configuration required — the AI handles everything.
3Commas costs $49 to $200+ per month, charged regardless of whether your bots are profitable. Endotech AI on Bit1 Exchange has zero upfront cost and no monthly subscription. The model is performance-only: 70% of trading profits go to you, 15% to Endotech, and 15% to the partner pool. You only pay when the AI makes you money.
No. 3Commas has no platform-level track record because results depend entirely on each user's bot configuration. Two users with different settings will have completely different results. Endotech AI has an 8-year verified live trading record: 163% average annual returns on BTC Alpha, 83% trade win rate, zero losing years in 8 years, and a maximum drawdown of 14%. This is a system-level track record, not user-dependent.
Endotech on Bit1 is significantly simpler to set up. With 3Commas, you must configure each bot manually — pairs, indicator settings, safety orders, risk parameters — requiring meaningful trading knowledge. With Endotech on Bit1: register, deposit USDT to Futures wallet, navigate to Copy Trading, select BTC Alpha or ETH Alpha, start. The AI handles all configuration and decisions. Setup takes under 10 minutes with zero trading knowledge required.
Most 3Commas DCA and grid bots are configured for sideways or upward markets. When price falls sharply and continuously, bots run out of safety orders, open positions accumulate at loss, and accounts can be severely damaged. Endotech AI trades futures in both directions — the system can profit from downward price movement. Its maximum drawdown during Bitcoin's -94% crash in 2018 was 14%.
Yes. Endotech AI runs on Bit1 Exchange through copy trading — completely separate from any 3Commas setup. You can run both simultaneously, or migrate capital from 3Commas to Bit1. Many traders transition after comparing the fee structure (monthly regardless of results vs performance-only) and the performance history (user-configured vs 8-year institutional track record).
Endotech vs 3Commas Endotech Wins
START SETUP
NETWORK: SECURE
Limitless Alpha

Master the Institutional
Architecture.

Join the private Limitless dispatch. Receive advanced Endotech deployment strategies, node updates, and algorithmic insights directly to your inbox.

Limitless Alpha

Get advanced AI deployment strategies and native integration updates sent privately to your inbox.